Zugriffe | |
---|---|
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 10 |
Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | Juni 2024 | Juli 2024 | |
---|---|---|---|---|---|---|---|
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
Zugriffe | |
---|---|
2023_Kreye_etal.pdf | 2 |